Iscador

Title	Average Rating
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract.	95.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador).	90.00%
Mistletoe therapy in oncology	90.00%
Mistletoe Therapy in Cancer	83.33%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador)	80.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort	80.00%
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit	50.00%
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera	50.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro,	50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u	50.00%
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm	20.00%

Languages